IL78934A - Alfuzosine compositions - Google Patents

Alfuzosine compositions

Info

Publication number
IL78934A
IL78934A IL78934A IL7893486A IL78934A IL 78934 A IL78934 A IL 78934A IL 78934 A IL78934 A IL 78934A IL 7893486 A IL7893486 A IL 7893486A IL 78934 A IL78934 A IL 78934A
Authority
IL
Israel
Prior art keywords
alfuzosine
compositions
alfuzosine compositions
Prior art date
Application number
IL78934A
Other languages
English (en)
Other versions
IL78934A0 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9319589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL78934(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL78934A0 publication Critical patent/IL78934A0/xx
Publication of IL78934A publication Critical patent/IL78934A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL78934A 1985-05-28 1986-05-27 Alfuzosine compositions IL78934A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8507950A FR2582513B1 (fr) 1985-05-28 1985-05-28 Compositions pharmaceutiques contenant de l'alfuzosine

Publications (2)

Publication Number Publication Date
IL78934A0 IL78934A0 (en) 1986-09-30
IL78934A true IL78934A (en) 1991-01-31

Family

ID=9319589

Family Applications (1)

Application Number Title Priority Date Filing Date
IL78934A IL78934A (en) 1985-05-28 1986-05-27 Alfuzosine compositions

Country Status (12)

Country Link
US (1) US4661491A (de)
EP (1) EP0204597B1 (de)
JP (1) JPS61277620A (de)
AU (1) AU586684B2 (de)
CA (1) CA1261755A (de)
DE (1) DE3683318D1 (de)
DK (1) DK168029B1 (de)
FR (1) FR2582513B1 (de)
HU (1) HUT46221A (de)
IE (1) IE58595B1 (de)
IL (1) IL78934A (de)
ZA (1) ZA863957B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2694495B1 (fr) * 1992-08-05 1994-09-23 Synthelabo Préparation pharmaceutique transdermique contenant de l'alfuzosine.
WO1994008040A1 (en) * 1992-09-25 1994-04-14 Synaptic Pharmaceutical Corporation Dna encoding human alpha 1 adrenergic receptors and uses thereof
US5861309A (en) 1992-09-25 1999-01-19 Synaptic Pharmaceutical Corporation DNA endoding human alpha 1 adrenergic receptors
WO1994009371A1 (en) * 1992-10-09 1994-04-28 Massachusetts Institute Of Technology Antemortem diagnostic test for alzheimer's disease
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
WO1997017967A1 (en) * 1995-11-15 1997-05-22 Merck & Co., Inc. ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
NZ334018A (en) * 1996-08-29 1999-06-29 Synthelabo Multilayered controlled release tablet comprising a layer of alfuzosin hydrochloride and at least one layer of hydrophillic polymers
FR2752737B1 (fr) * 1996-08-29 1998-10-02 Synthelabo Comprime a liberation controlee de chlorhydrate d'alfuzosine
US5922722A (en) * 1996-11-12 1999-07-13 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6214832B1 (en) 1997-06-18 2001-04-10 Merck & Co., Inc. Bis-piperidinyl-pyrimidin-2-ones as alpha 1a adrenergic receptor antagonists
US6057350A (en) * 1997-06-18 2000-05-02 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6080760A (en) * 1997-06-18 2000-06-27 Merck & Co., Inc. Alpha 1A adrenergic receptor antagonists
US6376503B1 (en) 1997-06-18 2002-04-23 Merck & Co., Inc Alpha 1a adrenergic receptor antagonists
US6143750A (en) * 1997-06-18 2000-11-07 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6037354A (en) * 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
WO2000006565A1 (en) 1998-07-30 2000-02-10 Merck & Co., Inc. ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
AU1808400A (en) 1998-10-29 2000-05-22 Merck & Co., Inc. Dihydropyridinones and pyrrolinones useful as alpha 1a adrenoceptor antagonists
US6228870B1 (en) 1998-11-10 2001-05-08 Merck & Co., Inc. Oxazolidinones useful as alpha 1a adrenoceptor antagonists
US6319932B1 (en) 1998-11-10 2001-11-20 Merck & Co., Inc. Oxazolidinones useful as alpha 1A adrenoceptor antagonists
WO2000029386A1 (en) 1998-11-12 2000-05-25 Merck & Co., Inc. Pyrimidinedione derivatives useful as alpha 1a adrenoceptor antagonists
US6358959B1 (en) 1999-01-26 2002-03-19 Merck & Co., Inc. Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists
GB2355457A (en) 1999-09-30 2001-04-25 Merck & Co Inc Novel spirotricyclic substituted azacycloalkane derivatives useful as alpha 1a adrenoceptor antagonists
GB2355263A (en) 1999-09-30 2001-04-18 Merck & Co Inc Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists
GB2355456A (en) 1999-09-30 2001-04-25 Merck & Co Inc Novel arylhydantoin derivatives useful as alpha 1a adrenoceptor antagonists
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
US20070105880A1 (en) * 2005-11-08 2007-05-10 Torrent Pharmaceuticals Limited Process for the preparation of alfuzosin
US20090069562A1 (en) * 2005-12-26 2009-03-12 Joseph Prabahar Koilpillai Process for the preparation of alfuzosin
US20100092556A1 (en) * 2006-12-11 2010-04-15 Kristin Arnold Alfuzosin formulations, methods of making, and methods of use
US20080160081A1 (en) * 2006-12-11 2008-07-03 Mutual Pharmaceutical Company, Inc. Alfuzosin formulations, methods of making, and methods of use
EP2042179A1 (de) * 2007-09-26 2009-04-01 sanofi-aventis Neue therapeutische Verwendung adrenerger alpha-1-Rezeptorantagonisten
US20100183717A1 (en) * 2009-01-16 2010-07-22 Kristin Arnold Controlled-release formulations
PL2915525T3 (pl) 2011-09-19 2022-01-17 Orexo Ab Tabletki podjęzykowe niepodatne na nadużywanie zawierające buprenorfinę i nalokson
US20160361380A1 (en) 2015-06-12 2016-12-15 Nymox Corporation Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
CN113599385B (zh) * 2021-08-20 2023-01-03 兰州大学 阿夫唑嗪在制备治疗糖尿病及其并发症药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466462A2 (fr) * 1978-02-06 1981-04-10 Synthelabo Derives d'alkylenediamines, leur preparation et leur application en therapeutique
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants

Also Published As

Publication number Publication date
AU5795186A (en) 1986-12-04
HUT46221A (en) 1988-10-28
IE861395L (en) 1986-11-28
EP0204597A2 (de) 1986-12-10
JPS61277620A (ja) 1986-12-08
CA1261755A (en) 1989-09-26
DE3683318D1 (de) 1992-02-20
DK168029B1 (da) 1994-01-24
EP0204597B1 (de) 1992-01-08
FR2582513A1 (fr) 1986-12-05
IE58595B1 (en) 1993-10-20
JPH0564930B2 (de) 1993-09-16
ZA863957B (en) 1987-01-28
DK246586D0 (da) 1986-05-27
EP0204597A3 (en) 1989-08-16
AU586684B2 (en) 1989-07-20
IL78934A0 (en) 1986-09-30
FR2582513B1 (fr) 1988-08-05
DK246586A (da) 1986-11-29
US4661491A (en) 1987-04-28

Similar Documents

Publication Publication Date Title
IL78934A (en) Alfuzosine compositions
GB8514052D0 (en) Compositions
GB8531635D0 (en) Composition
ZA865887B (en) Compositions
GB8508717D0 (en) Composition
GB8500862D0 (en) Composition
GB8509409D0 (en) Compositions
GB8524508D0 (en) Composition
GR860123B (en) Compositions
GB8504489D0 (en) Aminomethylenephosphonate compositions
GB8513550D0 (en) Compositions
EP0225309A3 (en) Aminomethylenephosphonate compositions
GB8514418D0 (en) Aminobenzylamine composition
ZA86355B (en) Compositions
GB8520289D0 (en) Compositions
GB8603048D0 (en) Lymphokine-containing compositions
EG17458A (en) Fungicial compositions
GB8516754D0 (en) Compositions
GB8514860D0 (en) Compositions
GB8527416D0 (en) Compositions
GB8527406D0 (en) Compositions
GB8617065D0 (en) Compositions
GB8526500D0 (en) Compositions
GB8526499D0 (en) Compositions
GB8526133D0 (en) Compositions

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired